If you lose a limb, your prosthesis could feature the brand's charging bull logo.

Some hardcore automotive fans might get a tattoo of their favorite brand, but true diehards might be able to make Lamborghini part of their body in the future. The Italian supercar maker is expanding its expertise in carbon fiber by launching a study into how to use the lightweight material for prosthetic implants and subcutaneous devices in the medical industry.

 


For this research, Lamborghini will work with the Houston Methodist Research Institute to create forms of carbon fiber that are better than the materials currently used in medicine. The company’s goal is to create something that’s lighter, more durable, and better tolerated by the human body. 

Lamborghini is pushing hard to become the industry leader in carbon fiber innovations. For example, the company opened a new research center for its Advanced Composite Structures Laboratory in Seattle, Washington, last year. The ACSL was previously responsible for creating the company’s proprietary Forged Composite carbon fiber process that made the lightweight material easier to sculpt into complicated shapes. The material premiered on the Sesto Elemento and recently helped the Huracán Performante shave off 90 pounds (41 kilograms) over the standard model.

Recent Lamborghini News:

Lambo is also working on developing carbon-fiber internal engine components for future production vehicles. The company believes that the parts could be lighter and stronger than traditional metal components. Reducing rotating mass inside the powerplant could create even quicker revving, more potent mills. In addition, the firm is working with Mitsubishi Rayon Company on a method to automate large-scale production of carbon-fiber-reinforced plastic. 

The company began using carbon fiber on its production vehicles about 30 years ago on the Countach Quattrovalvole. Now, the lightweight material is a staple of the company’s machines. If the new medical research project is a success, Lambo’s carbon fiber could be inside you, too.

Source: Lamborghini

Lamborghini Advanced Composite Structures Laboratory

Hide press releaseShow press release

AUTOMOBILI LAMBORGHINI STARTS BIOENGINEERING CARBON FIBER COMPOSITE STUDY WITH HOUSTON METHODIST RESEARCH INSTITUTE

 

Sant’Agata Bolognese/Houston (USA), 30 May 2017 – Automobili Lamborghini is collaborating with Houston Methodist Research Institute, to share its expertise in the study of carbon fiber composite materials.

The ongoing research project is focused on a biocompatibility study of composite materials to be used mainly in prosthetic implants, but also in subcutaneous devices. The aim is to identify new materials that are lighter, better tolerated by the human body, and more resistant over time than those currently used in the medical field.

Mauro Ferrari, Ph.D., President and CEO of the Houston Methodist Research Institute, was welcomed in Sant’Agata Bolognese by Stefano Domenicali, Chairman and Chief Executive Officer of Automobili Lamborghini.

Mauro Ferrari is an Italian scientist engaged mainly in nanotechnology research and in the field of applied bioengineering in medicine.

Automobili Lamborghini is a leader in the research and production of carbon fiber composite materials, and the Advanced Composite Lightweight Structures Department of Research & Development provides its experience not only in the automotive field but also in other sectors including biomedical.

In addition to Houston Methodist Research Institute, Lamborghini collaborates in Italy, on this and other research projects, with the Occupational Medicine Unit of Bologna University Hospital Authority St. Orsola-Malpighi Polyclinic (Prof. F.S. Violante, Dr. M.C. Nucci, Dr. V. Lodi), the Neurosurgery of IRCCS Institute of Neurological Sciences of Bologna (Dr. C. Sturiale, Dr. N. Acciarri), the Neurosurgery Humanitas University Rozzano-Milano (Prof F. Servadei), the CNR Institute of Neuroscience and Humanitas (Prof. M. Matteoli, Dr. M.L. Malosio) and IRCSS Rizzoli Orthopedic Institute of Bologna (Dr. S. Boriani, Dr. M. Girolami, Dr. M. Fini).